ADVI Health’s Yana Volman, solution leader for pharma Market Access, will participate in a panel discussion at the Texas BioLife Summit 2024 on February 21, 2024.
The panel discussion, entitled Commercializing New Products and Technology in Today’s Market, will explore the paths to commercialization and getting there with the least amount of resistance. The panel will cover distribution channels, FDA guidelines, advantaged payers, and barriers to commercialization for drugs.
We hope to see you there.
ADVI Team
Yana Volman
Head of Market Access Biopharma
